JDD Corner

Hypopigmented Mycosis Fungoides: A Clinical Mimicker of Vitiligo
Hypopigmented Mycosis Fungoides (HMF) Hypopigmented mycosis fungoides (HMF) is a rare variant of cutaneous T-cell lymphoma (CTCL) that often manifests in younger patients with darker skin types in a centripetal distribution.¹ Average age of diagnosis is often 14 years.² The diagnosis is often missed due to its low incidence and lack of clinical suspicion. Misdiagnosis and failure to obtain biopsies lead to a long latency period fr …
Hypopigmented Mycosis Fungoides (HMF)
Body Hair and Identity in Transgender Men: A Cross-Sectional Survey
body hair in transgender men Transgender and gender diverse people can experience increased depression, anxiety, suicidal ideation, and suicide from gender dysphoria (GD).1 GD occurs due to a discrepancy between a person’s gender identity, assigned gender, and physical characteristics.2 Gender affirming medical care, including dermatologic care, can increase body-gender congruence and decrease negative outcomes associ …
body hair in transgender men
Severe Ulcerative Perniosis Treated With Botulinum Toxin
Botulinum ToxinPerniosis (also known as pernio or chilblains), is a condition characterized by the development of pruritic, painful erythrocyanotic skin lesions induced by exposure to cold temperatures.² When perniosis occurs in conjunction with clinical or laboratory features of systemic lupus erythematosus, the condition is further classified as chilblain lupus erythematosus (CHLE). CHLE is a rare condition w …
Botulinum Toxin
JDD Issue Highlights | January 2022 | Aesthetic Treatments
Aesthetic TreatmentsThe Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights: Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation. …
Aesthetic Treatments
Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud’s Phenomenon
Refractory Raynaud’s PhenomenonRaynaud’s phenomenon is an exaggerated physiological response of blood vessels in the distal extremities to emotional stress and cold. It can be idiopathic or secondary to a connective tissue disorder, such as scleroderma or systemic lupus erythematosus. Treatment for Raynaud’s phenomenon consists primarily of lifestyle modifications; if unsuccessful, pharmacotherapy with dihydropyridine calci …
Refractory Raynaud’s Phenomenon